BANK OF AMERICA CORP /DE/ - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 62 filers reported holding UROGEN PHARMA LTD in Q3 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$607,165
+85.8%
43,338
+37.2%
0.00%
Q2 2023$326,842
-72.9%
31,579
-75.8%
0.00%
Q1 2023$1,206,882
+12.9%
130,615
+8.4%
0.00%
Q4 2022$1,068,622
+7.0%
120,476
+0.3%
0.00%
Q3 2022$999,000
-1.3%
120,072
-2.9%
0.00%
Q2 2022$1,012,000
-9.5%
123,607
-3.7%
0.00%
Q1 2022$1,118,000
+185.2%
128,317
+211.0%
0.00%
Q4 2021$392,000
-36.2%
41,262
+12.9%
0.00%
Q3 2021$614,000
-55.1%
36,543
-59.2%
0.00%
Q2 2021$1,369,000
+110.6%
89,635
+169.0%
0.00%
Q1 2021$650,000
+5.5%
33,322
-2.5%
0.00%
Q4 2020$616,000
+146.4%
34,186
+163.8%
0.00%
Q3 2020$250,000
-30.0%
12,959
-5.2%
0.00%
Q2 2020$357,000
+56.6%
13,665
+7.0%
0.00%
Q1 2020$228,000
-23.2%
12,770
+43.5%
0.00%
Q4 2019$297,000
+33.2%
8,899
-5.3%
0.00%
Q3 2019$223,000
-7.5%
9,399
+40.2%
0.00%
Q2 2019$241,000
-66.4%
6,704
-65.5%
0.00%
Q1 2019$717,000
+785.2%
19,424
+938.2%
0.00%
Q4 2018$81,000
+62.0%
1,871
+77.0%
0.00%
Q3 2018$50,000
-5.7%
1,0570.0%0.00%
Q2 2018$53,0001,0570.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Horton Capital Management, LLC 684,749$11,517,00023.27%
GREAT POINT PARTNERS LLC 750,000$12,615,0002.94%
HealthInvest Partners AB 75,000$1,262,0001.89%
Wildcat Capital Management, LLC 533,139$8,967,0001.16%
Annandale Capital, LLC 86,254$1,451,0000.87%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$49,698,0000.73%
ZEKE CAPITAL ADVISORS, LLC 723,677$12,172,0000.70%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$426,0000.34%
RTW INVESTMENTS, LP 857,464$14,423,0000.22%
SHIKIAR ASSET MANAGEMENT INC 33,350$561,0000.16%
View complete list of UROGEN PHARMA LTD shareholders